Trastuzumab

Trastuzumab
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

TITLE See full prescribing information for complete Boxed Warning. Condition Name: (Content)

Overview

Trastuzumab is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer. There is a Black Box Warning for this drug as shown here. Common adverse reactions include Edema， Peripheral edema， Tachycardia , Rash, Weight decreased, Abdominal pain，Diarrhea， Loss of appetite, Nausea, Stomatitis, Vomiting, Anemia, Neutropenia, Thrombocytopenia, Infectious disease, breast cancer, Arthralgia, Backache,Myalgia, Asthenia, Dizziness, Headache, Insomnia, Renal impairment, Cough, Dyspnea, Nasopharyngitis, Pharyngitis, Rhinitis, Upper respiratory infection, Fatigue, Fever, Inflammatory disease of mucous membrane, Shivering.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Trastuzumab FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Trastuzumab in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Trastuzumab in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Trastuzumab FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Trastuzumab in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Trastuzumab in pediatric patients.

Contraindications

There is limited information regarding Trastuzumab Contraindications in the drug label.

Warnings

TITLE See full prescribing information for complete Boxed Warning. Condition Name: (Content)

There is limited information regarding Trastuzumab Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Trastuzumab Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Trastuzumab Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Trastuzumab Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Trastuzumab in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Trastuzumab in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Trastuzumab during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Trastuzumab in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Trastuzumab in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Trastuzumab in geriatric settings.

Gender

There is no FDA guidance on the use of Trastuzumab with respect to specific gender populations.

Race

There is no FDA guidance on the use of Trastuzumab with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Trastuzumab in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Trastuzumab in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Trastuzumab in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Trastuzumab in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Trastuzumab Administration in the drug label.

Monitoring

There is limited information regarding Trastuzumab Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Trastuzumab and IV administrations.

Overdosage

There is limited information regarding Trastuzumab overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Trastuzumab Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Trastuzumab Mechanism of Action in the drug label.

Structure

There is limited information regarding Trastuzumab Structure in the drug label.

Pharmacodynamics

There is limited information regarding Trastuzumab Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Trastuzumab Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Trastuzumab Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Trastuzumab Clinical Studies in the drug label.

How Supplied

There is limited information regarding Trastuzumab How Supplied in the drug label.

Storage

There is limited information regarding Trastuzumab Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Trastuzumab |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Trastuzumab |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Trastuzumab Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Trastuzumab interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Trastuzumab Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Trastuzumab Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.